Surfactant for the Treatment of ARDS in a Patient With COVID-19

Patients with COVID-19 report severe respiratory symptoms consistent with ARDS. The clinical presentation of ARDS in COVID-19 is often atypical, as patients with COVID-19 exhibit a disproportionate hypoxemia compared with relatively preserved lung mechanics. This pattern is more similar to neonatal...

Descripción completa

Detalles Bibliográficos
Autores principales: Heching, Moshe, Lev, Shaul, Shitenberg, Dorit, Dicker, Dror, Kramer, Mordechai R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:
Novel Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825915/
https://www.ncbi.nlm.nih.gov/pubmed/33493441
http://dx.doi.org/10.1016/j.chest.2021.01.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825915/
https://www.ncbi.nlm.nih.gov/pubmed/33493441
http://dx.doi.org/10.1016/j.chest.2021.01.028

Ejemplares similares